Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,450 | 1 | 64.2% |
| Travel and Lodging | $873.58 | 4 | 22.9% |
| Food and Beverage | $492.95 | 4 | 12.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $3,662 | 7 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $103.48 | 1 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $50.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $154.25 | 2 | Mallinckrodt Hospital Products Inc. ($103.48) |
| 2019 | $3,662 | 7 | Relypsa, Inc. ($3,662) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Food and Beverage | In-kind items and services | $50.77 | General |
| Category: Hypertension | ||||||
| 06/19/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $103.48 | General |
| Category: CRITICAL CARE | ||||||
| 07/26/2019 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: Hyperkalemia | ||||||
| 07/26/2019 | Relypsa, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $69.56 | General |
| Category: Hyperkalemia | ||||||
| 07/12/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | Cash or cash equivalent | $213.70 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $388.60 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $311.12 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $104.30 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 637 | 1,074 | $205,764 | $50,622 |
| 2022 | 10 | 365 | 580 | $155,320 | $37,263 |
| 2021 | 9 | 352 | 664 | $203,125 | $46,505 |
| 2020 | 9 | 355 | 612 | $185,094 | $41,818 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 40 | 162 | $59,778 | $10,222 | 17.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 91 | $27,027 | $7,691 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 118 | $24,780 | $6,977 | 28.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 38 | $18,810 | $4,944 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 54 | 92 | $22,632 | $4,792 | 21.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 39 | 77 | $23,793 | $4,025 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 51 | $7,242 | $3,977 | 54.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 26 | $8,762 | $2,468 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 17 | $3,264 | $1,255 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 33 | $5,313 | $1,234 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $1,960 | $1,195 | 61.0% |
| 80069 | Kidney function blood test panel | Office | 2023 | 31 | 46 | $506.00 | $391.46 | 77.4% |
| 84156 | Total protein level, urine | Office | 2023 | 36 | 72 | $332.00 | $259.20 | 78.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 30 | 43 | $301.00 | $243.38 | 80.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 27 | 37 | $296.00 | $234.58 | 79.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 30 | 43 | $301.00 | $218.43 | 72.6% |
| 83735 | Magnesium level | Office | 2023 | 26 | 33 | $297.00 | $216.81 | 73.0% |
| 84550 | Uric acid level, blood | Office | 2023 | 25 | 35 | $210.00 | $155.05 | 73.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 29 | 40 | $160.00 | $124.40 | 77.8% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 30 | 105 | $38,745 | $6,966 | 18.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 42 | $20,790 | $6,500 | 31.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 38 | 67 | $19,899 | $5,281 | 26.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 90 | $18,900 | $4,902 | 25.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 50 | 80 | $24,720 | $4,542 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 54 | $13,284 | $2,913 | 21.9% |
About Eric Judd
Eric Judd is a Nephrology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972706067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Judd has received a total of $3,817 in payments from pharmaceutical and medical device companies, with $154.25 received in 2024. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($2,450).
As a Medicare-enrolled provider, Judd has provided services to 1,709 Medicare beneficiaries, totaling 2,930 services with total Medicare billing of $176,208. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Birmingham, AL
- Active Since 06/07/2007
- Last Updated 06/04/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1972706067
Products in Payments
- Veltassa (Drug) $3,662
- TERLIVAZ (Drug) $103.48
- Tryvio (Drug) $50.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Birmingham
David Warnock, Md, MD
Nephrology — Payments: $186,004
Eric Wallace
Nephrology — Payments: $137,132
Dana Rizk
Nephrology — Payments: $124,680
Michal Mrug
Nephrology — Payments: $92,833
Ashita Tolwani
Nephrology — Payments: $67,643
Timmy Lee
Nephrology — Payments: $38,311